VEGF in Signaling and Disease: Beyond Discovery and Development
Aflibercept | Clinical Cancer Research
The Role of VEGF and EGFR Inhibition: Implications for Combining Anti–VEGF and Anti–EGFR Agents | Molecular Cancer Research
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC - Journal of Thoracic Oncology
Understanding the mechanisms of action of antiangiogenic agents in metastatic colorectal cancer: A clinician's perspective - Cancer Treatment Reviews
Compensatory angiogenesis and tumor refractoriness | Oncogenesis
Mechanism of action of Ramucirumab. VEGF: vascular endothelial growth... | Download Scientific Diagram
Aflibercept in Pediatric Solid Tumors: Moving Beyond the Trap | Clinical Cancer Research
Possible mechanism involved in anti-VEGF therapy-induced posterior... | Download Scientific Diagram
Nephrotoxicity induced by intravitreal vascular endothelial growth factor inhibitors: emerging evidence - Kidney International
Cancers | Free Full-Text | Role of bFGF in Acquired Resistance upon Anti- VEGF Therapy in Cancer | HTML
Aflibercept mechanism of action. Aflibercept binds to VEGF A-D and PIGF... | Download Scientific Diagram
Angiogenesis inhibitor - Wikipedia
Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy | Diabetes Care
VEGF-targeted therapy: mechanisms of anti-tumour activity | Nature Reviews Cancer
The Role of Anti-vascular Endothelial Growth Factor Agents in the Management of Retinopathy of Prematurity - touchOPHTHALMOLOGY
Ocular Anti-VEGF Therapy for Diabetic Retinopathy: The Role of VEGF in the Pathogenesis of Diabetic Retinopathy | Diabetes Care
Vascular toxicities with VEGF inhibitor therapies–focus on hypertension and arterial thrombotic events - ScienceDirect
Anti-VEGF Therapy in Cancer: A Double-Edged Sword | IntechOpen
Effects of Novel Angiogenesis Inhibitors for the Treatment of Cancer on the Cardiovascular System | Circulation
Anti vegf' s in Ophthalmology
Frontiers | Therapy for Cancer: Strategy of Combining Anti-Angiogenic and Target Therapies | Cell and Developmental Biology
Anti-VEGF. Facts&Myths
Understanding and targeting resistance to anti-angiogenic therapies - Clarke - Journal of Gastrointestinal Oncology
